This inventor holds 1 USPTO granted patent. Top assignee: Istituto Superiore Di Sanita. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Maria Ferrantini: Innovator in Dendritic Cell Research
Introduction
Maria Ferrantini is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of immunology, particularly in the development of methods for generating highly active human dendritic cells. Her work is crucial for advancing therapeutic and prophylactic vaccination strategies.
Latest Patents
Maria Ferrantini holds a patent for a "Method for generating highly active human dendritic cells from peripheral blood mononuclear cells." This innovative process involves deriving dendritic cells from mononuclear cells in culture by contacting them with type I IFN. The resulting dendritic cells serve as effective cellular adjuvants in both prophylactic and therapeutic vaccinations for humans and animals. The invention also includes pharmaceutical compositions, vaccines, and methods for treating pathologies associated with antigens in humans.
Career Highlights
Maria Ferrantini is affiliated with the Istituto Superiore di Sanità, where she conducts her research. Her work has garnered attention for its potential to enhance vaccine efficacy and improve immune responses.
Collaborations
She collaborates with notable colleagues, including Tiziana Di Pucchio and Laura Santodonato, who contribute to her research endeavors.
Conclusion
Maria Ferrantini's innovative work in dendritic cell research exemplifies the impact of scientific advancements on healthcare. Her contributions are paving the way for improved vaccination strategies and therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile